🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Dental Dyschromia and Quality of Life in Early Prolonged Hyperbilirubinemia

Recruitingn/aAges 12 Years - 18 YearsAllUniversity Hospital, Toulouse
NCT06506734 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The main objective of this study is to assess the prevalence of dental discoloration (dental dyschromia) in children who experienced high levels of bilirubin in their blood (hyperbilirubinemia) during their early years. The study will also examine risk factors associated with this condition, such as the duration and severity of hyperbilirubinemia, underlying diseases, and treatments received. The researchers hypothesize that the quality of life of individuals with dental dyschromia is lower than that of individuals without dyschromia. The results of this study will be used to discuss coverage for dental care with health insurance for children affected by this condition.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * A patient with biliary atresia, progressive familial intrahepatic cholestasis, or Alagille syndrome * Patient or legal representative not opposed to participating in this research. Exclusion Criteria: * Inability to understand and respond to quality of life questionnaires
💊

What it tests

  • Questionnaires
📍

Where

9 sites
University Hospital Bordeaux
Bordeaux, France
University Hosptial Caen
Caen, France
University Hospital Lille
Lille, France
Hospices Civils de Lyon
Lyon, France
University Hospital Marseille
Marseille, France
Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, FHU Hépatinov
Paris, France
Assistance Publique-Hôpitaux de Paris, Hôpital Bretonneau, Paris
Paris, France
Assistance Publique-Hôpitaux de Paris, Hôpital Necker
Paris, France

…and 1 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy